BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, July 11, 2026
Home » Newsletters » BioWorld MedTech

BioWorld MedTech

June 6, 2019

View Archived Issues

FDA nod for soft exosuit from Rewalk, Wyss, to drive company to profitability in next few years

Rewalk Robotics Ltd. received U.S. FDA clearance for its second robotic medical device for people with lower limb disability. Known as the Restore soft exosuit system, it is cleared for use as part of physical therapy to aid stroke survivors with mobility problems. The Israeli company, which has additional headquarters in Marlborough, Mass., and Berlin, anticipates that the Restore soft exosuit may outstrip its existing Rewalk Personal 6.0 robotic exoskeleton for home use by patients with paralysis from spinal cord injury – and substantially contribute to a path to breakeven and profitability in the next couple of years. Read More

U.S. lawmakers seek way to undo SCOTUS 'patent mess'

Read More

Panel unanimously backs class II for surgical staplers

Read More

Virtual platform provides new path for health in Pakistan

KARACHI, Pakistan – Pakistan is running short of women doctors. That's not due to a lack of medical education facilities – 70% of all medical students are women – but because many of them leave midway through their careers. The Muslim-majority country now is looking to new medical technologies and telemedicine to address this issue. One startup that launched in 2017, Sehat Kahani, is relying on telemedicine to expand the reach of health care by, in large part, tapping into this pool of medical talent. Read More

HMP delivers insights into microbiome changes, stability

Read More

Daily M&A

Read More

Regulatory front

Read More

Appointments and advancements

Read More

Other news to note

Read More

Product clinical data for June 5, 2019

Read More

Product regulatory actions for June 5, 2019

Read More

BioWorld MedTech's Orthopedics Extra

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 10, 2026.
  • 3D rendering of an antibody drug conjugate

    ‘Target-high but uptake-defective’ state identified in ADC resistance

    BioWorld
    Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
  • Wainua autoinjector

    Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy

    BioWorld
    News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
  • Art concept for medical research

    FENS 2026: Shedding light on the sheddome

    BioWorld
    At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
  • Silhouette with keyhole

    FENS 2026: Next-gen biologics take on brain disease

    BioWorld
    Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing